Parameter | Reference interval |
---|---|
ROTEM EXTEM-MCF (maximal clot firmness) | 50–72 mm |
ROTEM EXTEM-CT (clotting time) | 38–79 mm |
ROTEM INTEM-MCF | 50–72 mm |
ROTEM INTEM-CT | 100–240 s |
ROTEM FIBTEM-MCF | 9–25 mm |
ROTEM HEPTEM-MCF | 50–72 mm |
ROTEM HEPTEM-CT | 100–240 s |
Multiplate® AUC (area under curve): ADPtest | 57–113 U |
Multiplate® AUC: COLtest | 72–125 U |
Multiplate® AUC: TRAPtest | 84–128 U |
Multiplate® AUC: ASPItest | 71–115 U |
P-FII | 0.70–1.50 kIE/L |
P-FVII | 0.60–1.60 kIE/L |
P-FX | 0.70–1.52 kIE/L |
P-FIX | 0.70–1.30 kIE/L |
P-FXI | 0.60–1.30 kIE/L |
P-FXII | 1.07–1.50 kIE/L |
P-FXIII | 0.70–1.40 kIE/L |
PT-INR | 0.9–1.1 |
aPTT | 26–33 s |
Platelet count (Plc) | Women 165–387 Men 145–348 × 109/L |
P-Fibrinogen | 2.0–4.0 mg/mL |
D-dimer | <0.25Â mg/L |
Gamma-glutamyltransferase (GT) | 0.2–1.9 μkat/L |
C-reactive protein (CRP) | <3.0Â mg/L |
Bilirubin | 5–25 μmol/L |
Alkaline phosphatase (ALP) | 0.6–1.8μkat/L |
Creatinine | 45–90 μmol/L |
Haemoglobin (Hb) | Women 117–153 g/L Men 134–170 |
PIVKA-II (protein induced by vitamin K absence) | <2.0Â mg/L |